Answer
Rufinamide causes concentration-dependent QTc shortening, so clinicians should use clinical judgment before prescribing it to patients with congenital short QT syndrome who may be at risk from further shortening, although the underlying mechanism and safety relevance are unknown.
Sources for this answer
- Rufinamide Eisai 100mg TabletsEisai Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 22Document updated
Sources checked